We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Relay Therapeutics Inc
8 own
4 watching
Current Price
$6.35
$0.45
(7.63%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,164.86M
52-Week High
13.32000
52-Week Low
5.71000
Average Volume
1.71M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,164.86M52-Week High13.3200052-Week Low5.71000Average Volume1.71MDividend Yield--P/E Ratio--What does the Relay Therapeutics Inc do?
We are a clinical-stage precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our company is built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. We were incorporated under the laws of the State of Delaware on May 4, 2015 under the name "Allostery, Inc." Our principal corporate office is located at 399 Binney Street, 2nd Floor, Cambridge, MA 02139, and our telephone number is (617) 370-8837. Our website address is www.relaytx.com.
Read More
How much money does Relay Therapeutics Inc make?
News & Events about Relay Therapeutics Inc.
Benzinga
1 year ago
Latest Ratings for RLAY
DateFirmActionFromTo Feb 2022BerenbergInitiates Coverage OnBuy Aug 2021HC Wainwright & Co.MaintainsBuy Jul 2021B of A SecuritiesInitiates Coverage OnBuy
View More Analyst Ratings for RLAY
View the Latest Analyst Ratings
read more...
Globe Newswire
1 year ago
Multiple doses achieved sustained target exposure of ~80%+ mutant PI3K inhibition No Grade 3 hyperglycemia, rash or diarrhea observed at target exposures Favorable initial safety profile at target exposures Confirmed partial response in breast cancer patient with 12 prior lines of therapy Initial ...
PR Newswire
1 year ago
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer PR Newswire VANCOUVER, British Columbia, March 24, 2023 FN Media Group Presents USA News Group News Commentary VANCOUVER...
Globe Newswire
1 year ago
Relay Therapeutics to host conference call following AACR presentationCAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and ...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in two fireside chats this month, at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 10:30 a.m. ET and the Barclays Global Healthcare Conference on ...
Frequently Asked Questions
Frequently Asked Questions
What is Relay Therapeutics Inc share price today?
Can Indians buy Relay Therapeutics Inc shares?
How can I buy Relay Therapeutics Inc shares from India?
Can Fractional shares of Relay Therapeutics Inc be purchased?
What are the documents required to start investing in Relay Therapeutics Inc stocks?
What is today’s traded volume of Relay Therapeutics Inc?
What is today’s market capitalisation of Relay Therapeutics Inc?
What is the 52-Week High and Low Range of Relay Therapeutics Inc?
What percentage is Relay Therapeutics Inc down from its 52-Week High?
What percentage is Relay Therapeutics Inc up from its 52-Week Low?
Current Price
$6.35
$0.45
(7.63%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.